For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

David Andrew D'Alessio, M.D. - Lindquist Presidential Distinguished Chair; Professor of Medicine; Chief, Division of ...

We all react to environmental cues that tell us it’s time to eat, like the scent of fries wafting through the air. These cues ...

Although GLP-1 medications may appear to be a solution ... “This medication is targeted to the underlying physiology of excessive appetite, more than normal appetite. And it literally changes ...

The quest for wellness is increasingly as much about the people you meet along the way as the physical health benefits. That ...

Through several experiments with mice, the researchers found that this previously unknown neuronal population that express ...

"These drugs would be distinct from Ozempic and other GLP-1 agonists, which stimulate insulin secretion. Leptin-targeting drugs could be beneficial for those who can't tolerate GLP-agonists due to ...

Retatrutide, a synthetic peptide with unique properties, has recently gained attention for its multifunctional roles and the ...

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower ...

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious ...

With its innovative features and the upcoming launch of a direct medication purchasing service, Gala is set to become the ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...